CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: Applying a novel discrete Bayes decision rule

This study was designed to determine the optimal combination of markers that predict recurrence in patients with T factors of T3/T4a stage II CRC by applying a novel Bayes decision rule.